Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track…
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded…
Data from eight participants continue to support safety and tolerability profile of tegoprubart Mean eGFR increased over the measurement period,…
Poster Presentation at the 2026 Crohn's & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize…
Statewide Practice Enrolling Patients in Global, Late-Phase Clinical Trial FORT MYERS, Fla., Jan. 22, 2026 /PRNewswire/ -- Florida Cancer Specialists…
Recognition based on innovation, growth, strategic initiatives and robust partnerships indelivering regulatory-grade RWESAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Verana Health®,…
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics.CAMBRIDGE, Mass., Jan.…
Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi® and Canalevia®-CA1,…
Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine technology ESTERO, FL / ACCESS…
Agreement leverages existing infrastructure to add contract-based revenue, improve asset utilization, support long-term cash flow and create shareholder value through…